Get the Stockscreener App
3.12
1.58%
-0.05
Heartsciences Inc stock is traded at $3.12, with a volume of 9,250.
It is down -1.58% in the last 24 hours and down -1.58% over the past month.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
See More
Previous Close:
$3.17
Open:
$3.12
24h Volume:
9,250
Relative Volume:
0.19
Market Cap:
$9.92M
Revenue:
-
Net Income/Loss:
$-7.29M
P/E Ratio:
-0.128
EPS:
-24.3686
Net Cash Flow:
$-6.81M
1W Performance:
+10.64%
1M Performance:
-1.58%
6M Performance:
-7.96%
1Y Performance:
-18.30%
1-Day Range:
$3.10
$3.13
1-Week Range:
$2.85
$3.25
52-Week Range:
$2.01
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
Name
Heartsciences Inc
Sector
Industry
Phone
682-237-7781
Address
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.12 | 10.07M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Heartsciences Inc Stock (HSCS) Latest News
Can HeartSciences Inc. Equity Warrant stock beat market expectations this quarter2025 Price Momentum & Accurate Trade Setup Notifications - mfd.ru
Market Review: What are HeartSciences Inc Equity Warrants earnings expectationsJuly 2025 Fed Impact & Safe Capital Growth Stock Tips - baoquankhu1.vn
Market Outlook: Whats the fair value of LINKBANCORP Inc stock2025 Fundamental Recap & Weekly Return Optimization Alerts - baoquankhu1.vn
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center - The Manila Times
HeartSciences Partners with University of the West of England to Establish Exclusive ECG Education and Technology Reference Center - Quiver Quantitative
UK university bets on AI ECG to train future NHS heart specialists - Stock Titan
Earnings Risk: Is HeartSciences Inc part of any ETFJuly 2025 Momentum & AI Forecasted Stock Moves - baoquankhu1.vn
Is HeartSciences Inc. Equity Warrant in a long term uptrendTrade Volume Report & Free Community Consensus Stock Picks - mfd.ru
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals - The Manila Times
123 community hospitals move to cloud ECG platform in new HeartSciences–Cibolo deal - Stock Titan
Panic Selling: Can HeartSciences Inc Equity Warrant sustain its profitabilityWeekly Profit Analysis & Safe Capital Growth Tips - baoquankhu1.vn
Growth Value: Will Investors Title Company outperform the market in YEARForecast Cut & Short-Term High Return Ideas - baoquankhu1.vn
Risks Report: Can HeartSciences Inc Equity Warrant ride the EV waveJuly 2025 Snapshot & Weekly High Momentum Picks - baoquankhu1.vn
Trend Review: Is HeartSciences Inc Equity Warrant attractive for institutional investorsJuly 2025 News Drivers & Fast Gain Swing Trade Alerts - baoquankhu1.vn
HeartSciences Secures New Private Financing Through Note Issuance - TipRanks
HeartSciences Signs Note Purchase Agreement With Streeterville Capital - TradingView
Trend Report: How HeartSciences Inc Equity Warrant stock reacts to oil pricesJuly 2025 Reactions & Real-Time Chart Breakout Alerts - Bộ Nội Vụ
HeartSciences Inc. announced that it has received $3 million in funding - marketscreener.com
Will HeartSciences Inc. Equity Warrant stock recover faster than peersJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - Улправда
Why hedge funds are buying HeartSciences Inc. Equity Warrant stockWeekly Profit Report & Fast Momentum Stock Entry Tips - Улправда
What hedge fund activity signals for HeartSciences Inc. Equity Warrant stockJuly 2025 Chart Watch & Verified Stock Trade Ideas - Улправда
Why HeartSciences Inc. Equity Warrant stock remains resilientMarket Performance Recap & High Return Trade Opportunity Guides - ulpravda.ru
Why HeartSciences Inc. Equity Warrant stock appeals to dividend seekersJuly 2025 News Drivers & Scalable Portfolio Growth Methods - ulpravda.ru
Can HeartSciences Inc. stock deliver sustainable ROEWeekly Earnings Recap & Growth Focused Entry Point Reports - Улправда
Will HeartSciences Inc. stock recover faster than peers2025 Sector Review & Momentum Based Trading Signals - Улправда
Is HeartSciences Inc. stock a safe haven asset2025 Volatility Report & Fast Gaining Stock Reports - Улправда
Buyout Rumor: Why HeartSciences Inc. Equity Warrant stock remains resilientJuly 2025 Chart Watch & High Conviction Buy Zone Picks - ulpravda.ru
Published on: 2026-01-12 22:13:00 - ulpravda.ru
Is HeartSciences Inc. Equity Warrant stock supported by strong cash flows2026 world cup usa national team group stage defensive leaders transition play odds analysis expert opinion - ulpravda.ru
What analysts say about HeartSciences Inc Equity Warrant stockMarket Depth Overview & Free Technical Analysis and Insights - Early Times
Market Meltdown the Virus and our ActionablesStock Price Divergence & Affordable Trading Strategies - bollywoodhelpline.com
Going all in on OTM options with low probabilities.Price Support Zones & Access Powerful Market Insights - bollywoodhelpline.com
Indo Count Industries Limited (ICIL) Expands into New MarketPrice-to-Book Ratio Updates & Exceptional Capital Growth - bollywoodhelpline.com
HeartSciences (NASDAQ:HSCS) Price Target Raised to $9.20 at Ascendiant Capital Markets - Defense World
HeartSciences (NASDAQ:HSCS) and Movano (NASDAQ:MOVE) Critical Survey - Defense World
Ascendiant Capital Maintains HeartSciences (HSCS) Buy Recommendation - Nasdaq
HeartSciences (HSCS) Receives Updated Analyst Rating and Price T - GuruFocus
HeartSciences (NASDAQ:HSCS) & Health Catalyst (NASDAQ:HCAT) Critical Analysis - Defense World
Does HeartSciences Inc. stock trade at a discount to peersJuly 2025 Spike Watch & Verified Swing Trading Watchlists - Улправда
Is HeartSciences Inc. Equity Warrant stock a top pick in earnings seasonEarnings Recap Report & Low Risk High Reward Ideas - Улправда
Why HeartSciences Inc. Equity Warrant stock could see breakout soon2025 Sector Review & Fast Entry High Yield Tips - Улправда
Will HeartSciences Inc. Equity Warrant stock attract ESG investorsMarket Weekly Review & Long Hold Capital Preservation Plans - Улправда
Will HeartSciences Inc. Equity Warrant stock deliver shareholder valueJuly 2025 Price Swings & Advanced Swing Trade Entry Plans - Улправда
History Review: Does HeartSciences Inc. stock trade at a discount to peers2025 Major Catalysts & Real-Time Volume Triggers - Улправда
HeartSciences Submits MyoVista wavECG Device for FDA Clearance - Diagnostic and Interventional Cardiology
HeartSciences approves indemnification agreements for directors and officers By Investing.com - Investing.com Nigeria
HeartSciences approves indemnification agreements for directors and officers - Investing.com
Heart Test Laboratories Approves Indemnification Agreement - TipRanks
Heartsciences Inc Stock (HSCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):